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olorectal cancer is the third most common cancer in men 
and the second most common in women worldwide.' It is 
the third leading cause of death in both sexes. The prevalence 
is higher, while mortality rate is lower in developed countries. 
However, there has been an increasing prevalence in patients 
under 50 years of age, and in these cases the mortality rate is also 
increasing.U 
The prognosis of rectal cancer is directly related to 
tun1our involvement of the mesorectum and the ability to 
achieve complete resection with tumour-free margins.• Tue 
ability of MRI to depict the the mesorectum and the e.nent 
of its involvment by the tumour has significantly improved 
treatment planning and outcomes. Figure l shows the rectum 
surrounded by the mesorectum, the latter being delimited by 
the mesorectal fascia (MRF). The most effective treatment for 
rectal cancer is complete surgical excision of the mesorectum, 
also known as Total Mesorectal Excision (TME). For tumours 
involving the MRF, also known as Locally Advanced Rectal 
Cancers, neoadju vant chemoradiotherapy can be used to shrink 
the tumour prior to TME. It is impor tant to note tllat the 
mesorectun1 thins out as it extends inferiorly and is absent at tile 
level of the anal sphincters. 
Neoadjuvant chemoradiotherapy results in a significant 
tumour downstaging in around half the patient treated, while in 
almost a third of [patients complete resolution of the tumour is 
observed. In the latter cases, some authors recommend follow-
up with no surgical intervention. 
Thus MRI of the rectum is used to distinguish patients 
who can go directly to surgery from those who would benefit 
from neoadjuvant chemoradiotherapy. In addition, it allows 
assessment of the effectiveness of neoadjuvant chemotllerapy, 
tailored surgical planning and post-operative follow-up/ 
restaging for tumour recurrence.s Poor prognostic factors such 
as extramural vascular invasion and mucin content can also be 
detected by MRI. 
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Figure 2 describes the staging rectal cancer based on MR 
findings, where T refers to tumour size/extent, N relates to the 
extent oflymph node disease and M refers to the presence and 
extent of distant metastases.6 TI, T2 and T3a and b tumours are 
treated directly with TME. T3c and d combined witl1 N I lesions 
receive short term radiotherapy followed by TME. T3 MRF+, 
T 4 or N2-staged lesions receive neoadjuvant chemotherapy and 
long term radiotherapy followed by a restaging MRI scan. 
There are different types ofTME, which are based on the 
distance of the tumour from the anal sphincters. For tumours 
located in the upper and middle rectum, a low anterior resection 
is performed, which preserves the inferior portion of tile rectum 
and anal sphincters and allows colorectal anastomosis. An ultra· 
Figure I. The mesorectum (M) surround~ the rectum (R) and is delimited by the 
Mesorectal Redal fascia (arrows). 
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Figure 2. TNM staging of rtct'al cancer. T refers to rwnour sizefextent, N relates 
to the extent oflymph Node ilisease, M refers Lo the presence and extent of 
distant Metasta..rs. 
low anterior resection may be possible in inferior rectal tumours, 
in which tile colorectal anastomosis is performed lcm below the 
tumour margin. For tumours less than lcm from tile anal verge 
an abdominal perineal (AP) resection is employed witll excision 
of the anus and sphincters and formation of a permanent 
colostomy; An intersphincteric AP re.section may be possible wit11 
sparing of the external sphincter. For more extensive tumours 
that infiltrate tile external sphincter or levator ani muscles, an 
extraelevator AP resection may be performed which includes a 
broader dissection of the perineal muscles. 
MRI staging of rectal cancer is based on Fast Spin Echo T2-
weighted images without fat suppression. These provide clear 
distinction between tile bowel wall layers, mesorectal fat and 
mesorectal fascia. The axial planes assess extent of invasion of 
bowel wall layers (Fig 3). Sagittal and coronal images depict the 
level of the tumour (upper, mid or lower rectum: 10.J-15cm, 5.I· 
lOcm and 0-Scm from the anal verge) (Fig 4a). Coronal im ages 
are also used to assess involvement of the internal or external anal 
sphinters (Fig 4b). Infiltration of the anterior peritoneal reflection, 
which is the peritoneum extending between the rectum and 
uterus or bladder, raises the tumour stage to T4a (Fig Sa). While 
infiltration of adjacent organs such as the prostate (Fig Sb) or 
seminal vesicles increases tumour stage to T 4b. 
Additional imaging sequences may be used in restaging 
including Diffusion- Weighted Imaging (DWI) with B-value 
>800secs/mm2 (Fig 6a) or contrast-enhanced fat-satuated 
T I-weighted imaging (Fig 6b). These imaging sequences are 
not required in the initial staging of rectal cancer, but they are 
useful for assessing residual tumour after chemoradiotherapy or 
surgery and for detection of tumour recurrence. 
Figure 3. Para-axial T2-weighted MR scan through the rectum (R) sh-0wing 
>5mm infiltration into the mesortctum (arrows) and > 3 suspicious mesorectal 
lymph nodes (arrowheads) (Stage T3cN2). Case c<iurlesy of Dr Natalie. Yang, 
Radiopaedia.org. rlD: 6990. 
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Figure 4. a. Coronal image T2·weighted MR scan through the r<ctum showing a rectal canctt (arrows). The levd of the cancrr is best as~sed on sagittal and coronal 
images. Cau courtuy of Dr Natalie Yang, Radiopaedia.org, r/D: 7124. b. Sparing of the internal (I) and external (E) anal sphincter is b•st oonfirmed on coronal T2· 
weighted images. (T - tumour) Ca St courtesy of Dr Natalie Yang. Radiopaedia.org, r/D: 7124. 
Figu« S. lnfiltration of the MRF. peritoneum and adjacent organs can 
be asseSS<d with axial T2·wright«I images. a. Infiltration of the peritoneal 
rdl<ction (arrowhead) betwttn the bladder and rectum (arrows) (stage T4a). 
b. Infiltration of the prostatt (arrow) (siage T4b). 
figure 6a. Transverse OWi image with high B-value taken through the 
mid-rectum follo"ing chemoradiotherapy shows areas of resi.dual tumour 
as bright arus within the rectum and mesorectum (arrows) as well as in 
involved lymph nodes in the mesorectum (arrowheads) (Stage T3Nl). 
C.2$ecourtcsy of Dr Natalit Yang. Radiopatdia.org. r/D: 7135. 
The above article provides but a superficial overview of 
the capabilities of MRI in staging rectal cancer. Numerous 
important details relating to imaging finding and staging 
of rectal cancer have been omitted here for the purpose of 
maintaining simplicity. More extensive and specific literature on 
the capabilities of MRI for rectal cancer staging is included in 
the references section. MRI of the rectum is an established and 
indispensible tool for staging rectal cancer and for monitoring 
response to therapy. :< 
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figure 6b. Conlrast-cnhanced fat-saturalcd Tl-weight«I scan of the rectum 
following chcmoradiothtrapy showing tumour Invading beyond the mesorectum 
(arrows) and the prostale (arrowhead) (P - proslate) (S1age T4b) Case courtesy 
of Dr Natalie Yang. Radiopaedia.org, r/D: 6989. 
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